Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to assess the clinical efficacy of siltuximab, demonstrated by a reduction in RBC transfusions to treat the anemia of MDS.
Critère d'inclusion
- Anemia associated with Low- or Intermediate-1-Risk Myelodysplastic
- Syndrome